ArticleMolecular cancer therapeutics2019

Atovaquone: An Antiprotozoal Drug Suppresses Primary and Resistant Breast Tumor Growth by Inhibiting HER2/β-Catenin Signaling.

Nehal Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.